Follow
'In practice, drug manufacturers often benefit from market exclusivity lasting well beyond the date of expiration of their key patent plus PTE. This is because for successful drugs, manufacturers commonly fortify and extend their market exclusivity periods by seeking and receiving multiple additional patents as the drugs proceed through development and even after FDA approval'
